STOCK TITAN

Lazard (LAZ) SEC Filings

LAZ NYSE

Lazard, Inc. filings document the regulatory record for a financial advisory and asset management company listed on the NYSE under LAZ. Form 8-K reports furnish quarterly and annual results, Regulation FD strategy updates, material agreements, executive officer changes, compensation arrangements, and other material-event disclosures tied to the firm’s advisory and asset management businesses.

Proxy materials cover board elections, governance practices, executive compensation and shareholder voting matters. The company’s risk-factor disclosures address conditions in global and regional financial markets, M&A activity, assets under management, liquidity, third-party exposures and competition, alongside capital-structure and reporting matters.

Rhea-AI Summary

Lazard, Inc. director Stephen R. Howe Jr. received an award of 113 Deferred Stock Units on November 16, 2026. His reported direct position afterward was 14,956 Deferred Stock Units. Howe elected annually to receive DSUs in lieu of all or part of cash compensation under the non-executive director compensation arrangement. The DSUs convert into common stock one-for-one after he resigns or otherwise ceases to be a board member.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
insider
-
Rhea-AI Summary

Lazard, Inc. Chief Operating Officer Alexandra Soto acquired 3,814 restricted stock units on November 13, 2026, under dividend equivalent reinvestment provisions of underlying RSU awards. Each RSU represents a contingent right to receive one share of common stock. Her reported position following the transaction was 311,848 RSUs; that amount excludes 148,185 shares of common stock she directly or indirectly beneficially owns.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
insider
-
Rhea-AI Summary

Lazard, Inc. reported that Christopher Hogbin, CEO Asset Management, acquired 3,301 restricted stock units on November 13, 2026, through dividend equivalent reinvestment provisions of underlying RSU awards. His reported post-transaction position was 269,960 RSUs; that amount excludes 11,829 shares of common stock directly or indirectly beneficially owned by him.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
insider
Rhea-AI Summary

Lazard, Inc. Chief Financial Officer Tracy Farr acquired 477 restricted stock units (RSUs) on November 13, 2026, pursuant to the dividend equivalent reinvestment provisions of underlying RSU awards. Each RSU represents a contingent right to receive one share of common stock. Farr’s reported direct RSU holdings after the acquisition were 38,872. A reported amount excludes 2,889 shares of common stock directly or indirectly beneficially owned by Farr.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.69%
Tags
insider
-
Rhea-AI Summary

Lazard, Inc. reported $648,807,630 USD of equity securities sold in an offering connected to its acquisition of 100% of the outstanding ownership interests of Campbell Lutyens Holdings Limited. The amount is a good-faith estimate assuming full earnout achievement and payment in shares. Consideration comprises upfront, deferred and contingent earnout amounts; deferred and earnout consideration may instead be paid in loan notes at Lazard’s option. Total remaining to be sold is $0 USD.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.00%
Tags
other
-
Rhea-AI Summary

Lazard, Inc. filed a prospectus supplement relating to the possible resale of up to 9,416,817 shares of its common stock. The shares were issued to selling stockholders in connection with the previously announced acquisition of 100% of the outstanding ownership interests of Campbell Lutyens Holdings Limited.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.21%
Tags
current report
Rhea-AI Summary

Lazard, Inc. registered for resale by the selling stockholders up to 9,416,817 shares of common stock; Lazard is not selling shares and will receive no proceeds from their sales. The selling stockholders decide when and how to sell, subject to contractual transfer restrictions, and may sell some, all or none of the shares.

The resale shares were issued as consideration in Lazard’s completed acquisition of Campbell Lutyens on November 1, 2026. At closing, Lazard issued 9,651,777 shares as initial consideration and paid approximately $93.2 million in cash. Of the 9,416,817 shares registered for resale, 2,955,669 are subject to contractual lock-ups that lapse in installments on November 1, 2027, November 1, 2028 and November 1, 2029; 6,461,148 are not subject to those lock-ups.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.21%
Tags
prospectus
-
Rhea-AI Summary

Lazard, Inc. (LAZ) completed its acquisition of 100% of Campbell Lutyens Holdings Limited on November 1, 2026. Initial consideration included 9,651,777 common shares issued only to accredited sellers, with the share count determined using a $46.50 reference price, and approximately $93.2 million in cash. The agreement also provides for $115 million payable on the second anniversary of closing and earn-out consideration of up to $85 million based on revenue-growth targets through 2030, subject to a potential extension.

Deferred and earn-out consideration may be settled, at Lazard’s election, in shares, loan notes or both, subject to a 19.99% cap on aggregate shares issuable under the agreement. Lazard launched Lazard CL, combining more than 300 advisory professionals across 19 offices. Lazard continues to anticipate approximately $500 million in estimated combined revenue and earnings accretion in 2027 before revenue or expense synergies. Holders may request shelf underwritten offerings for shares not subject to lock-up when they reasonably expect gross proceeds above $80 million; Lazard is not obligated to effect more than four total or more than one in any 120-calendar-day period.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.11%
Tags
current report
-
Rhea-AI Summary

Lazard, Inc. reported third-quarter 2026 total revenue of $836.4 million, versus $770.8 million a year earlier, while net income attributable to Lazard fell to $29.2 million from $71.2 million. Diluted earnings per share were $0.26, compared with $0.65. Financial Advisory net revenue was $468.6 million, versus $427.3 million; Asset Management net revenue was $353.2 million, versus $327.0 million. For the first nine months, net cash provided by operating activities was $300.6 million, versus $119.6 million.

Lazard completed the sale of a controlling stake in Edgewater on February 13, 2026, recording a $75.5 million pretax gain, and obtained a controlling financial interest in Elaia on June 30, 2026. It agreed to acquire Campbell Lutyens for initial closing consideration of $460 million, subject to cash, debt and working capital adjustments at closing; deferred consideration of $115 million payable on the second anniversary of closing; and earn-out consideration of up to $85 million tied to performance criteria and certain selling shareholders’ continued employment. The deal is expected to close in early November, subject to customary closing conditions. The board declared a quarterly dividend of $0.50 per share, payable November 13, 2026, to holders of record November 2, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.25%
Tags
quarterly report
Rhea-AI Summary

Lazard, Inc. (LAZ) reported third-quarter 2026 U.S. GAAP net revenue of $814 million, up 9% year over year, and adjusted (non-GAAP) net revenue of $805 million, up 11%. GAAP net income was $29 million ($0.26 diluted per share), down 59%; adjusted net income was $40 million ($0.36 per share), down 35%. For the first nine months, GAAP net revenue rose 8% to $2,378 million while GAAP net income fell 28% to $135 million. Adjusted net income was $100 million, down 44%.

Quarterly Financial Advisory revenue rose 10% to $470 million and Asset Management revenue rose 9% to $357 million. Average AUM was $287 billion, up 11% year over year; ending AUM was $284 billion, up 7%. Nine-month net flows were positive $5.1 billion, while third-quarter net outflows were $2.3 billion. Lazard returned $88 million to shareholders in the quarter, declared a $0.50-per-share dividend payable November 13, 2026, and reported $1,264 million in cash and cash equivalents as of September 30, 2026. Management aims for an adjusted compensation ratio of 60% or below and an adjusted non-compensation ratio between 16% and 20%, with timing dependent on market conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
current report

FAQ

How many Lazard (LAZ) SEC filings are available on StockTitan?

StockTitan tracks 115 SEC filings for Lazard (LAZ), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Lazard (LAZ)?

The most recent SEC filing for Lazard (LAZ) was filed on November 17, 2026.